Evidence map›Paper›PMID 29568682›Full record

ArticleBrain and behavior2018

Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus.

Minoru Maruyama, Natsu Hotta, Yasunori Nio, Kenichi Hamagami, Toshimi Nagi, Masaaki Funata, Junichi Sakamoto, Masanori Nakakariya, Nobuyuki Amano, Mayumi Nishida and 7 more

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Minoru MaruyamaCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.ORCID 0000-0002-1478-9415
Natsu HottaCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Yasunori NioExtra Value Generation & General Medicine Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Kenichi HamagamiCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Toshimi NagiCentral Nervous System Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Masaaki FunataBiomolecular Research Laboratories Takeda Pharmaceutical Company Limited Kanagawa Japan.
Junichi SakamotoBiomolecular Research Laboratories Takeda Pharmaceutical Company Limited Kanagawa Japan.
Masanori NakakariyaDrug Metabolism and Pharmacokinetics Research LaboratoriesTakeda Pharmaceutical Company Limited Kanagawa Japan.
Nobuyuki AmanoDrug Metabolism and Pharmacokinetics Research LaboratoriesTakeda Pharmaceutical Company Limited Kanagawa Japan.
Mayumi NishidaIntegrated Technology Research Laboratories Takeda Pharmaceutical Company Limited Kanagawa Japan.
Tomohiro OkawaCentral Nervous System Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Yasuyoshi ArikawaCentral Nervous System Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Shinobu SasakiMedicinal Chemistry Research Laboratories Pharmaceutical Research Division Takeda Pharmaceutical Company Limited Kanagawa Japan.
Shizuo KasaiCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Yasutaka NagisaCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Yugo HabataCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Masaaki MoriCardiovascular and Metabolic Drug Discovery Unit Takeda Pharmaceutical Company Limited Kanagawa Japan.
Takeda (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Bombesin receptor subtype-3 (BRS-3) has been suggested to play a potential role in energy homeostasis. However, the physiological mechanism of BRS-3 on energy homeostasis remains unknown. Thus, we investigated the BRS-3-mediated neuronal pathway involved in food intake and energy expenditure. Materials and Methods: Expression of BRS-3 in the rat brain was histologically examined. The BRS-3 neurons activated by refeeding-induced satiety or a BRS-3 agonist were identified by c-Fos immunostaining. We also analyzed expression changes in feeding-relating peptides in the brain of fasted rats administered with the BRS-3 agonist. Results: In the paraventricular hypothalamic nucleus (PVH), dorsomedial hypothalamic nucleus (DMH), and medial preoptic area (MPA), strong c-Fos induction was observed in the BRS-3 neurons especially in PVH after refeeding. However, the BRS-3 neurons in the PVH did not express feeding-regulating peptides, while the BRS-3 agonist administration induced c-Fos expression in the DMH and MPA, which were not refeeding-sensitive, as well as in the PVH. The BRS-3 agonist administration changed the Conclusion: These results suggest that BRS-3 neurons in the PVH are a novel functional subdivision in the PVH that regulates feeding behavior. As the MPA and DMH are reportedly involved in thermoregulation and energy metabolism, the BRS-3 neurons in the MPA/DMH might mediate the energy expenditure control. POMC and CART may contribute to BRS-3 neuron-mediated energy homeostasis regulation. In summary, BRS-3-expressing neurons could regulate energy homeostasis through a novel neuronal pathway.

Indexed as

AnimalsCHO CellsCocaine- and Amphetamine-Regulated Transcript ProteinCricetulusEatingEnergy MetabolismFeeding BehaviorHomeostasisHypothalamusMaleMice, KnockoutNerve Tissue ProteinsNeuronsRatsRats, Sprague-DawleyReceptors, Bombesinbombesin receptor subtype 3Cocaine- and Amphetamine-Regulated Transcript ProteinMchr1 protein, mouseNerve Tissue ProteinsReceptors, BombesinReceptors, Somatostatinbombesin receptor subtype‐3energy homeostasishypothalamusneuronal pathwayobesity

Identifiers

PMID29568682
PMCPMC5853643
OpenAlexW2775183137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.